Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9452162
APP PUB NO 20150182521A1
SERIAL NO

14406776

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
IPSEN BIOPHARM LTDWREXHAM

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bayever, Eliel New York, US 26 196
Dhindsa, Navreet Boston, US 17 114
Fitzgerald, Jonathan Basil Cambridge, US 43 295
Kim, Jaeyeon Lexington, US 70 441
Laivins, Peter Rowayton, US 17 114
Moyo, Victor Concord, US 42 244
Niyikiza, Clet Gulph Mills, US 75 448

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 27, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00